Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder

被引:98
作者
Cappellen, D
deMedina, SGD
Chopin, D
Thiery, JP
Radvanyi, F
机构
[1] INST CURIE,CNRS,UMR 144,SECT RECH,F-75248 PARIS 05,FRANCE
[2] CHU HENRI MONDOR,GRP ETUD TUMEURS UROL,F-94010 CRETEIL,FRANCE
[3] CHU HENRI MONDOR,UROL SERV,F-94010 CRETEIL,FRANCE
关键词
bladder; human; transitional cell carcinoma; tumour progression; chromosome; 10; loss of heterozygosity;
D O I
10.1038/sj.onc.1201154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Loss of heterozygosity (LOH) on chromosome 10 has been observed in several human cancers including glioblastomas, meningiomas, melanomas and endometrial and prostate carcinomas, We have investigated the incidence of LOH on chromosome 10 in 36 human transitional cell carcinomas (TCCs) of the bladder, three upper urinary tract TCCs and one lymph node metastasis, using a panel of 27 highly polymorphic markers spanning 10p (short arm) and 10q (long arm), Fourteen bladder tumours (39%), the three upper urinary tract tumours and the lymph node metastasis showed LOH for at least one locus on chromosome 10, Remarkably, LOH on chromosome 10 was observed mainly in muscle-invasive (P=0.01) and high grade tumours (P=0.03). For five tumours and the lymph node metastasis, LOH was found at all informative loci, indicating monosomy or isodisomy of chromosome 10, The deletion mapping of the tumours with partial loss delineated two minimal regions of loss on chromosome 10q, One region, the most telomeric, was bounded by markers D10S214 and D10S169 and the other, the most proximal, was bounded by markers D10S222 and D10S531, Our results demonstrate that chromosome 10q LOH is common in muscle-invasive bladder cancers and that two potential tumour suppressor loci, at 10q24.1-q24.3 and 10q26.1-q26.2, may contribute to the malignant progression of these tumours. Localization of the smallest common regions of loss in bladder tumours provides a starting point for the identification of the genes involved.
引用
收藏
页码:3059 / 3066
页数:8
相关论文
共 47 条
  • [31] POLASCIK TJ, 1995, CANCER RES, V55, P5396
  • [32] RASHEED BKA, 1995, ONCOGENE, V10, P2243
  • [33] RODRIGUEZ E, 1994, CANCER RES, V54, P3398
  • [34] ROSIN MP, 1995, CANCER RES, V55, P5213
  • [35] RUPPERT JM, 1993, CANCER RES, V53, P5093
  • [36] IDENTIFICATION OF P53 GENE-MUTATIONS IN BLADDER CANCERS AND URINE SAMPLES
    SIDRANSKY, D
    VONESCHENBACH, A
    TSAI, YC
    JONES, P
    SUMMERHAYES, I
    MARSHALL, F
    PAUL, M
    GREEN, P
    HAMILTON, SR
    FROST, P
    VOGELSTEIN, B
    [J]. SCIENCE, 1991, 252 (5006) : 706 - 709
  • [37] CLONAL ORIGIN OF BLADDER-CANCER
    SIDRANSKY, D
    FROST, P
    VONESCHENBACH, A
    OYASU, R
    PREISINGER, AC
    VOGELSTEIN, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (11) : 737 - 740
  • [38] SIMON M, 1995, CANCER RES, V55, P4696
  • [39] CHROMOSOMAL ANALYSIS OF BLADDER-CANCER .3. NONRANDOM ALTERATIONS
    SMEETS, W
    PAUWELS, R
    LAARAKKERS, L
    DEBRUYNE, F
    GERAEDTS, J
    [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 29 (01) : 29 - 41
  • [40] SPIESSL B, 1992, TNM ATLAS ILLUSTRATE, P214